CAW
HZNP

Cornerstone Advisors (Washington)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-847
Closed -$10K – 946
2017
Q2 		$10K Hold
847
– – 0.01% 584
2017
Q1 		$13K Hold
847
– – 0.01% 560
2016
Q4 		$14K Hold
847
– – 0.01% 557
2016
Q3 		$15K Hold
847
– – 0.01% 551
2016
Q2 		$14K Hold
847
– – 0.01% 364
2016
Q1 		$14K Hold
847
– – 0.01% 359
2015
Q4 		$18K Hold
847
– – 0.02% 335
2015
Q3 		$17K Buy
+847
New +$26.8K 0.02% 359

Other funds holding HZNP

SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Cornerstone Advisors (Washington)'s HZNP Position: Q3 2017 in Review

Cornerstone Advisors (Washington) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2017, closing a stake of 847 shares — an estimated $10K sold.

Cornerstone Advisors (Washington) first reported a position in HZNP in Q3 2015 and held it in 8 quarters. The position peaked at $18K in Q4 2015. 181 funds tracked by Wall St. Rank hold HZNP as of Q3 2017.

  • Cornerstone Advisors (Washington) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2017 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 847 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2017, an estimated $10K.
  • Cornerstone Advisors (Washington) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 8 quarters.
  • Cornerstone Advisors (Washington)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $18K in Q4 2015.
  • 181 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2017.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2017, filed 25 Oct 2017.